APA (7th ed.) Citation

DL, J., KS, C., P, D., S, B., M, Z., CM, P., . . . S, L. (2024). Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants. The Journal of infectious diseases, 230(5), 1224. https://doi.org/10.1093/infdis/jiae308

Chicago Style (17th ed.) Citation

DL, Jacobson, et al. "Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants." The Journal of Infectious Diseases 230, no. 5 (2024): 1224. https://doi.org/10.1093/infdis/jiae308.

MLA (9th ed.) Citation

DL, Jacobson, et al. "Dolutegravir- Versus Efavirenz-Based Treatment in Pregnancy: Impact on Red Blood Cell Folate Concentrations in Pregnant Women and Their Infants." The Journal of Infectious Diseases, vol. 230, no. 5, 2024, p. 1224, https://doi.org/10.1093/infdis/jiae308.